Study of SU11248 in Men With Advanced Prostate Cancer

NCT00299741 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Sunitinib

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]